SYNOLIS V-A

The first intra-articular Visco-Antalgic

The V-A Effect: Intense, Fast Prolonged Pain Relief

Intense Pain Relief *
68% average pain reduction at 12 weeks after treatment initiation

Fast Pain Relief **
2/3 of patients are experiencing a noticeable pain relief just one week after the 1st injection

Prolonged Pain Relief **
Over 80% of patients are still experiencing treatment’s benefits 6 months after the 1st injection

Pain relief curve  Synolis V-A

SYNOLIS V-A
A unique combination of Hyaluronic Acid (2%) & sorbitol (4%)

Highly stable
Sorbitol protects Hyaluronic Acid (HA) from degradation

Counterbalancing oxidative stress
Sorbitol is an anti-oxidant that neutralises free radicals that are a major cause of the osteoarthritis evolution

Offering adaptive visco-elasticity
Like healthy human synovial fluid, Synolis V-A displays viscosity & elasticity properties that adapt to the need of lubrication or shock absorption.

* data on file: Non-Interventional Study including a population of: 152 patients with 50% Kellgren Gr. II & 50% Gr. III & with Moderate or Severe Initial Pain, receiving 3 injections of Synolis V-A. Initial average walking pain at 2.6 on 5-point Likert scale.

** data on file: Non-Interventional Study including a population of 997 patients with all level of pain or grades, receiving 1 or 3 injections of Synolis V-A

Cookies help us deliver our services. By using our services, you agree to our use of cookies. More Info | Close

We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.